A Mastery Approach to Complex Esophageal DiseasesEsophageal Cancer
A Mastery Approach to Complex Esophageal Diseases: Esophageal Cancer
Boshier, P. R.; Wirsching, A.; Low, Donald E.
2018-04-21 00:00:00
[Esophageal cancer is a major global health burden affecting 746,000 individuals and responsible for 459,300 deaths in 2015. Important contributing factors in the development of this disease can include: history of gastrointestinal reflux disease, high rates of visceral obesity, Caucasian race, smoking, and male gender. Symptoms of early esophageal cancer are often vague and non-specific, which makes timely diagnosis even more difficult. Although no routine screening programs currently exist, upper gastrointestinal endoscopy with esophageal biopsy remains the gold standard diagnostic test. Several therapies are available, such as endoscopic therapy, chemotherapy and chemoradiotherapy, and esophagectomy. The overall 5 year survival rate in the United States ranges from 19% to 47%, depending on the staging of the disease.]
http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.pnghttp://www.deepdyve.com/lp/springer-journals/a-mastery-approach-to-complex-esophageal-diseases-esophageal-cancer-d7BoDAR040
A Mastery Approach to Complex Esophageal DiseasesEsophageal Cancer
[Esophageal cancer is a major global health burden affecting 746,000 individuals and responsible for 459,300 deaths in 2015. Important contributing factors in the development of this disease can include: history of gastrointestinal reflux disease, high rates of visceral obesity, Caucasian race, smoking, and male gender. Symptoms of early esophageal cancer are often vague and non-specific, which makes timely diagnosis even more difficult. Although no routine screening programs currently exist, upper gastrointestinal endoscopy with esophageal biopsy remains the gold standard diagnostic test. Several therapies are available, such as endoscopic therapy, chemotherapy and chemoradiotherapy, and esophagectomy. The overall 5 year survival rate in the United States ranges from 19% to 47%, depending on the staging of the disease.]
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.